Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Centogene (CNTGF)
OTHER OTC:CNTGF
Holding CNTGF?
Track your performance easily
CNTGF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.06 - $1.53
Previous Close$0.14
Volume3.66K
Average Volume (3M)184.04K
Market Cap
$4.09M
Enterprise Value$72.43M
Total Cash (Recent Filing)€19.10M
Total Debt (Recent Filing)€80.73M
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Sep 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.37
Shares Outstanding27,595,835
10 Day Avg. Volume20,940
30 Day Avg. Volume184,040
Standard Deviation0.25
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.15
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Centogene News
PremiumCompany Announcements
Centogene N.V. Seeks New Auditor for 2024
PremiumCompany Announcements
Centogene N.V. Supervisory Board Reshuffle and CFO TalksOwnership Overview
0.00%
Insiders
0.04% Mutual Funds
0.61% Other Institutional Investors
99.35% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CNTGF FAQ
What was Centogene’s price range in the past 12 months?
Centogene lowest stock price was $0.06 and its highest was $1.53 in the past 12 months.
What is Centogene’s market cap?
Currently, no data Available
When is Centogene’s upcoming earnings report date?
Centogene’s upcoming earnings report date is Sep 03, 2025 which is in 348 days.
How were Centogene’s earnings last quarter?
Currently, no data Available
Is Centogene overvalued?
According to Wall Street analysts Centogene’s price is currently Overvalued.
Does Centogene pay dividends?
Centogene does not currently pay dividends.
What is Centogene’s EPS estimate?
Centogene’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Centogene have?
Centogene has 29,000,137 shares outstanding.
What happened to Centogene’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Centogene?
Among the largest hedge funds holding Centogene’s share is Platinum Investment Management. It holds Centogene’s shares valued at N/A.
---
Centogene Stock Smart Score
Company Description
Centogene
Centogene NV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
---
CNTGF Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---